Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05309460 · ClinicalTrials.gov registry record · Phase 4
Labetalol or Nifedipine for Control of Postpartum Hypertension: A Randomized Controlled Trial
A Phase 4 study of Hypertension in Pregnancy and Postpartum Preeclampsia, sponsored by Nebraska Methodist Health System.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 600
- Enrollment target
- 1
- Study location
NCT05309460 is a Phase 4 study of Hypertension in Pregnancy and Postpartum Preeclampsia that is actively recruiting participants, run by Nebraska Methodist Health System. The registered enrollment target is 600 participants, above the 402-participant average among 13 other Hypertension in Pregnancy trials with a reported enrollment target (49% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05309460, a Phase 4 study of Hypertension in Pregnancy and Postpartum Preeclampsia, is actively recruiting participants, sponsored by Nebraska Methodist Health System.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 600 participants
- Enrollment target
- 1
- Study location
Study Summary
Randomized trial comparing risk of hospital readmission and hypertensive complications between patients managed on Labetalol compared to Nifedipine.
Conditions Studied
Interventions
- DRUG Labetalol Oral Tablet
- DRUG NIFEdipine ER
Study Locations (1)
Nebraska
- Nebraska Methodist Women's Hospital - Omaha
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2022-06-20 |
| Est. Completion | 2024-12-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05309460
The ClinicalTrials.gov registry entry for NCT05309460 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 402-participant average among 13 other Hypertension in Pregnancy trials with a reported enrollment target (49% higher). The listed sponsor is Nebraska Methodist Health System, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Hypertension in Pregnancy appearing as the primary indexed condition, and to 2 interventions - of which Labetalol Oral Tablet is the first listed.
NCT05309460 reports 1 study location spanning 1 distinct geographic area - top geographies include Nebraska.
Frequently Asked Questions
What is clinical trial NCT05309460 about?
NCT05309460 is a clinical study titled "Labetalol or Nifedipine for Control of Postpartum Hypertension: A Randomized Controlled Trial". Randomized trial comparing risk of hospital readmission and hypertensive complications between patients managed on Labetalol compared to Nifedipine.
What is the current status of trial NCT05309460?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 600 participants. The study started on 2022-06-20. Estimated completion is 2024-12-01.
What conditions does trial NCT05309460 study?
This clinical trial studies the following conditions: Hypertension in Pregnancy, Postpartum Preeclampsia.
What interventions are being tested in trial NCT05309460?
The interventions under investigation include: Labetalol Oral Tablet (DRUG), NIFEdipine ER (DRUG).
Who is sponsoring clinical trial NCT05309460?
This trial is sponsored by Nebraska Methodist Health System, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05309460 being conducted?
This trial has 1 study location across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertension in Pregnancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Postpartum Evaluation of Nifedipine and Enalapril for Hypertension
RECRUITING · Phase 4
-
A Randomized, Placebo-controlled Trial of DAPAgliflozin (DAPA) for Cardiovascular Risk Reduction in the Postpartum Period of Hypertensive Pregnancies (HP)
RECRUITING · Phase 4
-
Conical Forearm and Cylindrical Upper Arm Non-Invasive Blood Pressure (NIBP) Measurements in Pregnant Patients
RECRUITING · NA
-
Moms@Home: A Storytelling-based Mobile Health Intervention to Improve Blood Pressure Management in Pregnancy
RECRUITING · NA
-
Rhode Island - Statewide Postpartum Hypertension Remote Surveillance
RECRUITING · NA
-
Chronic Hypertension and Pregnancy 2 (CHAP2) Pilot Project
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.